Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.0 - $3.28 $34,600 - $56,744
-17,300 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$3.14 - $5.15 $3,140 - $5,150
-1,000 Reduced 5.46%
17,300 $57,000
Q4 2020

Feb 12, 2021

BUY
$6.99 - $9.26 $29,358 - $38,892
4,200 Added 29.79%
18,300 $146,000
Q3 2020

Nov 13, 2020

BUY
$8.49 - $19.54 $119,709 - $275,514
14,100 New
14,100 $130,000
Q1 2020

May 11, 2020

SELL
$6.94 - $14.22 $173,500 - $355,500
-25,000 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$7.99 - $37.6 $33,558 - $157,920
-4,200 Reduced 14.38%
25,000 $200,000
Q3 2019

Nov 14, 2019

BUY
$19.17 - $27.4 $385,317 - $550,740
20,100 Added 220.88%
29,200 $595,000
Q2 2019

Aug 20, 2019

BUY
$22.93 - $42.84 $208,663 - $389,844
9,100 New
9,100 $237,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.